ShreeOswal Seeds And Chemicals Limited has informed the Exchange regarding Board meeting held on August 12, 2025 for consider and approval of Un-audited standalone and consolidated Financial Results of the Company for the quarter ended on 30th June, 2025
OSWALSEEDS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ShreeOswal Seeds and Chemicals reported strong Q1 FY26 results on both standalone and consolidated basis. Standalone revenue from operations grew 37.7% YoY to ₹6,959.21 lakhs (vs ₹5,052.61 lakhs in Q1 FY25), while net profit surged 214% to ₹720.81 lakhs (vs ₹229.67 lakhs). Consolidated revenue rose 27.3% YoY to ₹9,794.98 lakhs and the company swung to a net profit of ₹728.03 lakhs from a loss of ₹271.55 lakhs a year ago. The Seeds Division drove the recovery, with segment profit jumping to ₹1,008.16 lakhs (vs ₹304.07 lakhs), while the Psyllium Division also turned profitable at ₹106.41 lakhs (vs a loss of ₹518.38 lakhs). Standalone EPS improved to ₹0.79 from ₹0.25, and consolidated EPS to ₹0.80 from a negative ₹0.30. Statutory auditor J.C. Baheti & Associates issued an unmodified review opinion on both sets of results.
Sharp YoY revenue and profit growth, supported by a turnaround in the Psyllium segment and strong momentum in Seeds, is likely to be viewed positively by investors and could support near-term stock sentiment. Investors should wait for the full results PDF for segment-level margin and cost detail.